5 years pharmaceutical or biotech sales experience
3 years oncology or rare disease experience
Mastery of clinical knowledge for avutometinib and defactinib
This role involves preparing and executing the launch of two new products, Avutometinib and Defactinib, specifically for low grade serous ovarian cancer
Job Summary
This role involves preparing and executing the launch of two new products, Avutometinib and Defactinib, specifically for low grade serous ovarian cancer.
The selected candidate will serve as the face of Verastem Oncology, utilizing clinical acumen to formulate strategies that identify benefits for customers.
IQVIA offers a comprehensive benefit plan effective day one including health, dental, vision, 401k, and tuition assistance, while the client offers potential equity participation.
Matching Summary
This role involves preparing and executing the launch of two new products, Avutometinib and Defactinib, specifically for low grade serous ovarian cancer.
Salary
Base: $170,000 - $200,000 annually; Bonus/Equity: Potential equity program with client; Benefits: Health, Dental, Vision, 401k, Tuition Assistance, Discretionary Time Off
Skills & Requirements
Must-have
5 years pharmaceutical or biotech sales experience
3 years oncology or rare disease experience
Mastery of clinical knowledge for Avutometinib and Defactinib
Ability to execute new product launches in LGSOC
50% overnight travel capability required
Nice-to-have
Women's health or GYN/Oncology background preferred
Experience launching new products or indications
Strong relationships in ovarian cancer space
Oral drug experience preferred
Passionate self-motivated individual with strong teamwork
Key Requirements
Minimum BA/BS degree required
Minimum 5 years relevant pharmaceutical/biotech sales experience
Minimum 3 years oncology/rare disease experience
Valid driver's license and clean driving record
Compliance with customer credentialing and safety requirements